MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Environmental toxins"

  • 2019 International Congress

    Frequency of PD Non-Motor symptoms in healthy factory workers

    C. Guerra-Galicia, C. Tenorio (San Luis Potosí, Mexico)

    Objective: To measure the prevalence of Parkinson's disease non-motor symptoms (PD NMS Quest, spanish version) among three different types of factory workers: tire factory, chemical…
  • 2019 International Congress

    Environmental toxicants and Parkinson’s disease in south of Morocco

    Y. Naji, N. Kissani (Marrakech, Morocco)

    Objective: Focus on epidemiologic data for environmental agents as potential risk factors throw our experience in third level hospital of Marrakesh Morocco. Background: This multidisciplinary…
  • 2019 International Congress

    Impact of cathine and carthinone use among Parkinson’s disease Patients

    S. Zewde (Addis Ababa, Ethiopia)

    Objective: Evaluate cathine and cathinone’s effect on alertness, energy, sleep pattern, and tremor among Parkinson’s disease patient. Background: Khat, a plant that contains amphetamine like…
  • 2018 International Congress

    Oculomotor Behavior in Healthy Caribbean: Does it reflect an increased vulnerability to degenerative Parkinsonism?

    A. Lannuzel, A. Lackmy, B. Tressières, R. Edragas, V. Pélonde-Erimée, C. Bonnet, S. Rivaud-Péchoux, E. Roze, B. Gaymard (Pointe-à-Pitre, Guadeloupe)

    Objective: To investigate the impact of environmental factors on eye movement performances in two populations composed of carefully selected healthy subjects with strikingly different ethnic…
  • 2017 International Congress

    Occupational trichloroethylene exposure and Parkinson’s disease risk

    S. Goldman, P. Quinlan, C. Meng, K. Comyns, G.W. Ross, K. Marek, C. Tanner (San Francisco, CA, USA)

    Objective: To assess whether occupational exposure to the solvent trichloroethylene (TCE) is associated with increased risk of Parkinson's disease (PD). Background: Severe solvent intoxication can…
  • 2017 International Congress

    Two-year prospective study reveals that gut dysbiosis predicts progression of Parkinson’s disease

    M. Hirayama, T. Minato, Y. Fujisawa, H. Tsuji, T. Asahara, K. Nomoto, T. Maeda, K. Ohno (Nagoya, Japan)

    Objective:  This study is to examine whether intestinal microbiota correlate with pathology progress of PD severity and change of gut microbiota for 2 years. Background:…
  • 2017 International Congress

    Exposure to bifenthrin contributes to Parkinson’s disease in mouse model

    C. Han, S. Liu, J. Huang, L. Liu, K. Ma, X. Guo, S. Guo, L. Wang, Y. Shen, Y. Xia, F. Wan, N. Xiong, T. Wang (Wuhan, China)

    Objective: To explore the relationship between pyrethroid bifenthrin and Parkinson’s disease on mouse model. Background: Pyrethroid is now widely used on account of its high…
  • 2016 International Congress

    Serum levels of polychlorinated biphenyls, CYP2B6 and neurodegenerative disease in the Faroe Islands

    L.L. Farrell, E. Nosova, S. Bech, I. Guella, M.J. Farrer, M.S. Petersen (Vancouver, BC, Canada)

    Objective: To investigate genetic variability in CYP2B6, PCB levels and Parkinson's disease in the Faroese. Background: Polychlorinated biphenyls (PCBs) are persistent man-made highly toxic pollutants…
  • 2016 International Congress

    Long-term incidence of Parkinson’s disease in rural areas of Finland

    J. Isotalo, T. Vahlberg, V. Kaasinen (Turku, Finland)

    Objective: To investigate possible long-term changes in the incidence of Parkinson's disease (PD) in rural regions. Background: Living in rural areas has long been suspected…
  • 2016 International Congress

    Rotenone and Parkinson’s disease (PD): Effect modification by membrane transporter variants

    S.M. Goldman, F. Kamel, C. Meng, M. Korell, D.M. Umbach, J. Hoppin, G.W. Ross, C. Marras, M. Kasten, A. Chade, K. Comyns, D. Sandler, A. Blair, C.M. Tanner (San Francisco, CA, USA)

    Objective: Determine whether variants in the xenobiotic efflux membrane transporter p-glycoprotein gene (ABCB1, p-gp, MDR1) modify the association of rotenone and PD. Background: Use of…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley